Article
The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options.
International journal of obesity (2005) - 1 Feb 2014
Fani L, Bak S, Delhanty P, van Rossum E F C, van den Akker E L T
Abstract excerpt
Obesity is one of the greatest public health challenges of the 21st century. Obesity is currently responsible for ∼0.7-2.8% of a country's health costs worldwide. Treatment is often not effective because weight regulation is complex. Appetite and energy control are regulated in the brain. Melanocortin-4 receptor (MC4R) has a central role in this regulation. MC4R defects lead to a severe clinical phenotype with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
